Dr. Marks will discuss the work of this important FDA center, which is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.

This summit will seek solutions to the specific economic gaps limiting the advancement of precision medicine. PMC Senior Vice President for Science Policy Daryl Pritchard will contribute to the discussions. Learn more at https://www.diaceutics.com/articles/multi-stakeholder-group-bring-a-unique-economic-solution-to-the-clinical-practice-gaps-holding-back-precision-medicine.